Drug Trial Radar · NCT02507167
Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8
Last checked: Nov 19, 2026Latest source record: Jul 23, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
19
Actual
Start
Nov 2012
Primary completion
Jul 2013
Study completion Dec 2014
Sponsor
- Lead sponsor
- University Medicine GreifswaldAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 23, 2015
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the impact of genetic variants of OATP 1B3 or MRP 2 on the systemic disposition of endogenously formed CCK-8 and to determine the influence of a single-dose of the transporter inhibitor rifampin (600 mg) on the systemic disposition of endogenously formed CCK-8. Endogenous CCK-8 secretion will be induced by a single-dose standardized liquid mixed meal.
Conditions
- Gastrointestinal Hormones
Interventions
mixed mealDietary supplement
250 ml Fortimel compact (chocolate)
RifampinDrug
oral rifampin administration (600 mg EREMFAT®)
Primary outcomes
What the sponsor says the trial is designed to measure.
- CCK-8Time frame: 3 h 15 min up to 2 h 15 min before and 5, 10, 15, 20, 25, 30, 45 min, 1, 1.25, 1.5, 2, 3, 4 h after mixed meal
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Clinical Pharmacology
Greifswald, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.